18F-Radiolabeling and Preliminary Evaluation of a HSP90 ligand

作者: P. Nordeman , Z.P. Jayendra , E. Briard , S.C. Li , M. Larhed

DOI: 10.1016/J.EJPS.2020.105647

关键词: Leaving groupLigand (biochemistry)RadiochemistryIn vitroMetabolismChemistryTosylFrozen section procedureIn vivoHsp90

摘要: Abstract Purpose With the ambition of improving management pancreatic neuroendocrine tumors (P-NETs), we developed and preliminary validated a novel fluorine-18 labelled HSP90 ligand. Methods A precursor containing methoxymethyl ethers protecting groups tosyl as leaving group was synthesized. The target compound labeled with nucleophilic 18F-fluoride subsequently removed hydrochloric acid before purification. In vitro cell- frozen section autoradiography in vivo animal studies were performed. Results successfully synthesized utilized 18F-radiolabeling giving 0.5-1.0 GBq pure product synthesis time 70 min. experiments indicated high specific binding, but showed no tumor uptake due to fast hepatobiliary metabolism excretion. Conclusions Despite unfavorable properties tracer, promising results from sections P-NETs surgical resection encourage us continue project aiming improvement tracer.

参考文章(19)
Gabriela Chiosis, Brian Krichevsky, John Gerecitano, Pat Zanzonico, Shanu Modi, Komal Jhaveri, Jason Lewis, Mark Dunphy, Steven Larson, Louise Harris, First-in-human trial of Hsp90-targeted PET imaging The Journal of Nuclear Medicine. ,vol. 53, pp. 344- 344 ,(2012)
L. Whitesell, S. Santagata, N.U. Lin, Inhibiting HSP90 to treat cancer: a strategy in evolution. Current Molecular Medicine. ,vol. 12, pp. 1108- 1124 ,(2012) , 10.2174/156652412803306657
Paul A. Brough, Wynne Aherne, Xavier Barril, Jenifer Borgognoni, Kathy Boxall, Julie E. Cansfield, Kwai-Ming J. Cheung, Ian Collins, Nicholas G. M. Davies, Martin J. Drysdale, Brian Dymock, Suzanne A. Eccles, Harry Finch, Alexandra Fink, Angela Hayes, Robert Howes, Roderick E. Hubbard, Karen James, Allan M. Jordan, Andrea Lockie, Vanessa Martins, Andrew Massey, Thomas P. Matthews, Edward McDonald, Christopher J. Northfield, Laurence H. Pearl, Chrisostomos Prodromou, Stuart Ray, Florence I. Raynaud, Stephen D. Roughley, Swee Y. Sharp, Allan Surgenor, D. Lee Walmsley, Paul Webb, Mike Wood, Paul Workman, Lisa Wright, 4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer Journal of Medicinal Chemistry. ,vol. 51, pp. 196- 218 ,(2007) , 10.1021/JM701018H
Toshihiko Doi, Yusuke Onozawa, Nozomu Fuse, Takayuki Yoshino, Kentaro Yamazaki, Junichiro Watanabe, Mikhail Akimov, Matthew Robson, Narikazu Boku, Atsushi Ohtsu, Phase I dose-escalation study of the HSP90 inhibitor AUY922 in Japanese patients with advanced solid tumors Cancer Chemotherapy and Pharmacology. ,vol. 74, pp. 629- 636 ,(2014) , 10.1007/S00280-014-2521-X
Lemonitsa H. Mammatas, Henk M. W. Verheul, N. Harry Hendrikse, Maqsood Yaqub, Adriaan A. Lammertsma, C. Willemien Menke-van der Houven van Oordt, Molecular imaging of targeted therapies with positron emission tomography: the visualization of personalized cancer care Cellular Oncology. ,vol. 38, pp. 49- 64 ,(2015) , 10.1007/S13402-014-0194-4
Seong Jong Kim, Deborah M. Ramsey, Cyrille Boyer, Thomas P. Davis, Shelli R. McAlpine, Effectively delivering a unique hsp90 inhibitor using star polymers. ACS Medicinal Chemistry Letters. ,vol. 4, pp. 915- 920 ,(2013) , 10.1021/ML400082B
Marco A. Biamonte, Ryan Van de Water, Joseph W. Arndt, Robert H. Scannevin, Daniel Perret, Wen-Cherng Lee, Heat shock protein 90: inhibitors in clinical trials. Journal of Medicinal Chemistry. ,vol. 53, pp. 3- 17 ,(2010) , 10.1021/JM9004708
Aviral Jain, Sanjay Jain, PEGylation: an approach for drug delivery. A review. Critical Reviews in Therapeutic Drug Carrier Systems. ,vol. 25, pp. 403- 447 ,(2008) , 10.1615/CRITREVTHERDRUGCARRIERSYST.V25.I5.10
Wenjun Li, Peng Zhan, Erik De Clercq, Hongxiang Lou, Xinyong Liu, Current drug research on PEGylation with small molecular agents Progress in Polymer Science. ,vol. 38, pp. 421- 444 ,(2013) , 10.1016/J.PROGPOLYMSCI.2012.07.006
Michael M. Schmidt, K. Dane Wittrup, A modeling analysis of the effects of molecular size and binding affinity on tumor targeting Molecular Cancer Therapeutics. ,vol. 8, pp. 2861- 2871 ,(2009) , 10.1158/1535-7163.MCT-09-0195